Privium Fund Management (UK)’s Lam Research LRCX Stock Holding History

Privium Fund Management (UK)’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,450	Closed	-$1.34M	–	91
2024 Q2	$1.34M	Buy	12,450 +7,390	+146%	+$709K	0.52%	46
2024 Q1	$497K	Buy	+5,060	New	+$445K	0.25%	58

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Privium Fund Management (UK)'s LRCX Position: Q3 2024 in Review

Privium Fund Management (UK) sold out of Lam Research (LRCX) in Q3 2024, closing a stake of 12,450 shares — an estimated $1.34M sold.

Privium Fund Management (UK) first reported a position in LRCX in Q1 2024 and held it in 2 quarters. The position peaked at $1.34M in Q2 2024. 1,464 funds tracked by Wall St. Rank hold LRCX as of Q3 2024.

Privium Fund Management (UK) reported no remaining Lam Research position as of Q3 2024 after selling out during the quarter.
Privium Fund Management (UK) sold 12,450 Lam Research shares in Q3 2024, an estimated $1.34M.
Privium Fund Management (UK) first reported a position in Lam Research in Q1 2024 and held it in 2 quarters.
Privium Fund Management (UK)'s Lam Research position peaked at $1.34M in Q2 2024.
1,464 funds tracked by Wall St. Rank held Lam Research as of Q3 2024.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2024, filed 5 Nov 2024.